Short-term Interim Results of Clinical Outcomes and Complications After Implantation of Boston Keratoprosthesis in Japanese Patients.
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
pubmed:
15
9
2020
medline:
18
9
2021
entrez:
14
9
2020
Statut:
ppublish
Résumé
Keratoprosthesis is used for corneal transplantation in high-risk patients who require penetrating keratoplasty (PKP). Boston keratoprosthesis (BKpro) is a representative type of keratoprosthesis used worldwide. In Japan, the first BKpro was implanted in an eye after multiple corneal graft failures in 2008, but its use remains limited. A recent patient survey revealed that among the Japanese patients who had previously undergone multiple PKPs, the retention rate of BKpro was significantly higher than that of PKP at 5 years postoperatively (100% vs. 26%; P < 0.01). Patients with implanted BKpro also had better best corrected visual acuity of 20/200 or higher than those with PKP at 5 years postoperatively (80.0% vs. 17.6%; P = 0.03). Regarding the postoperative complications, retroprosthetic membrane formation was observed in 88.9%, infectious keratitis in 33.3%, and glaucoma progression in 11.1% of cases. Another retrospective analysis showed that fungal keratitis occurred in 0.09 patients per year and severely affected visual acuity. Furthermore, because it is difficult to accurately examine intraocular pressure after BKpro implantation, the intraocular pressure of patients with implanted BKpro was prospectively estimated using a transpalpebral tonometer (Diaton). In conclusion, BKpro implantation is effective and safe for Japanese patients, given the reported improvements in visual acuity and low rates of complications.
Identifiants
pubmed: 32925428
doi: 10.1097/ICO.0000000000002453
pii: 00003226-202011001-00005
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S28-S33Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Aravena C, Yu F, Aldave AJ. Long-term visual outcomes, complications, and retention of the Boston type I keratoprosthesis. Cornea. 2018;37:3–10.
Srikumaran D, Munoz B, Aldave AJ, et al. Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology. 2014;121:2159–2164.
Aravena C, Bozkurt TK, Yu F, et al. Long-term outcomes of the Boston type I keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2016;35:1156–1164.
Gibbons A, Leung EH, Haddock LJ, et al. Long-term outcomes of the aphakic snap-on Boston type I keratoprosthesis at the Bascom Palmer Eye Institute. Clin Ophthalmol. 2018;12:331–337.
Priddy J, Bardan AS, Tawfik HS, et al. Systematic review and meta-analysis of the medium- and long-term outcomes of the Boston type 1 keratoprosthesis. Cornea. 2019;38:1465–1473.
Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea. 2009;28:321–327.
Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol. 2011;46:164–168.
Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119:1530–1538.
Hassanaly SI, Talajic JC, Harissi-Dagher M. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. Am J Ophthalmol. 2014;158:270–276.e1.
Sravani NG, Mohamed A, Sangwan VS. Type 1 Boston keratoprosthesis for limbal stem cell deficiency in epidermolysis bullosa. Ocul Immunol Inflamm. 2019;27:282–284.
Ono T, Ishiyama S, Hayashidera T, et al. Twelve-year follow-up of penetrating keratoplasty. Jpn J Ophthalmol. 2017;61:131–136.
Boston Kpro news. Available at: https://eye.hms.harvard.edu/files/eye/files/kpro_2019_newsletterfinalweb.pdf. Accessed July 7, 2020.
Ono T, Iwasaki T, Miyata K. Fungal keratitis after Boston keratoprosthesis. JAMA Ophthalmol. 2017;135:e173272.
de Quengsy T. Precis au cours d’opération sur la chirurgie des yeux [in French]. Paris, France: Dido & Mequigno; 1789.
Cortina MS, Cruz J, eds. Keratoprostheses and Artificial Corneas. New York, NY: Springer; 2015.
Strampelli B. Keratoprosthesis with osteodontal tissue. Am J Ophthalmol. 1963;89:1029–1039.
Hicks CR, Crawford GJ, Lou X, et al. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye (Lond). 2003;17:385–392.
Schrage N, Hille K, Cursiefen C. Current treatment options with artificial corneas: Boston Kpro, Osteo-odontokeratoprosthesis, Miro Cornea and KeraKlear [in German]. Ophthalmologe. 2014;111:1010–1018.
Dohlman CH, Schneider HA, Doane MG. Prosthokeratoplasty. Am J Ophthalmol. 1974;77:694–670.
Fukuda M, Hamada S, Liu C, et al. Osteo-odonto-keratoprosthesis in Japan. Cornea. 2008;27(suppl 1):S56–S61.
Iyer G, Srinivasan B, Agarwal S, et al. Boston type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India. Ocul Surf. 2019;17:50–54.
Lee R, Khoueir Z, Tsikata E, et al. Long-term visual outcomes and complications of Boston keratoprosthesis type II implantation. Ophthalmology. 2017;124:27–35.
Mori Y, Nejima R, Minami K, et al. Three cases of Boston keratoprosthesis implantation for repeated graft failure observed for more than one year [in Japanese]. J Eye. 2011;28:1191–1196.
Alexander JK, Basak SK, Padilla MD, et al. International outcomes of the Boston type I keratoprosthesis in Stevens-Johnson Syndrome. Cornea. 2015;34:1387–1394.
Mori Y, Ono T, Nejima R, et al. Comparison of Boston keratoprosthesis and penetrating keratoplasty in eyes after multiple corneal graft failure [in Japanese]. J Eye. 2016;33:1503–1508.
Ono T, Mori Y, Ueda K, et al. Investigation of fungal keratitis following Boston keratoprosthesis implantation [in Japanese]. J Jpn Ophthalmol Soc. 2018;122:509–515.
Risma JM, Tehrani S, Wang K, et al. The utility of Diaton tonometer measurements in patients with ocular hypertension, glaucoma, and glaucoma tube shunts: a preliminary study for its potential use in keratoprosthesis patients. J Glaucoma. 2016;25:643–647.
Akpek EK, Cassard SD, Dunlap K, et al. Donor corneal transplantation vs Boston type 1 keratoprosthesis in patients with previous graft failures: a retrospective single center study (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2015;113:T3.
Lu LM, Boyle AB, Niederer RL, et al. Repeat corneal transplantation in Auckland, New Zealand: indications, visual outcomes and risk factors for repeat keratoplasty failure. Clin Exp Ophthalmol. 2019;47:987–994.
Zerbe BL, Belin MW, Ciolino JB, et al. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113:1779.e1–1779.e7.
Ciolino JB, Belin MW, Todani A, et al. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2013;120:1195–1200.
Rudnisky CJ, Belin MW, Guo R, et al. Visual acuity outcomes of the Boston keratoprosthesis type 1: multicenter study results. Am J Ophthalmol. 2016;162:89–98.e1.
Ahmad S, Mathews PM, Srikumaran D, et al. Outcomes of repeat Boston type 1 keratoprosthesis implantation. Am J Ophthalmol. 2016;161:181–187.e1.
Wang JC, Rudnisky CJ, Belin MW, et al. Outcomes of Boston keratoprosthesis type 1 reimplantation: multicentre study results. Can J Ophthalmol. 2018;53:284–290.
Cortina MS, Hallak JA. Vision-related quality-of-life assessment using NEI VFQ-25 in patients after Boston keratoprosthesis implantation. Cornea. 2015;34:160–164.
Lee WB, Shtein RM, Kaufman SC, et al. Boston keratoprosthesis: outcomes and complications: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122:1504–1511.
Moshiri A, Safi M, Morse LS, et al. Posterior segment complications and impact on long-term visual outcomes in eyes with a type 1 Boston keratoprosthesis. Cornea. 2019;38:1111–1116.
Goldman DR, Hubschman JP, Aldave AJ, et al. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina. 2013;33:532–541.
Kornberg DL, Yannuzzi NA, Klufas MA, et al. Ultra-widefield imaging of posterior segment pathology in the setting of the Boston keratoprosthesis. Retina. 2016;36:1101–1110.
Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96:776–780.
Odorcic S, Haas W, Gilmore MS, et al. Fungal infections after Boston type 1 keratoprosthesis implantation: literature review and in vitro antifungal activity of hypochlorous acid. Cornea. 2015;34:1599–1605.
Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea. 2007;26:9–15.
Lin CC, Chen A, Jeng BH, et al. Scleral intraocular pressure measurement in cadaver eyes pre- and postkeratoprosthesis implantation. Invest Ophthalmol Vis Sci. 2014;55:2244–2250.
Enders P, Hall J, Bornhauser M, et al. Telemetric intraocular pressure monitoring after Boston keratoprosthesis surgery with the Eyemate-IO sensor: dynamics in the first year. Am J Ophthalmol. 2019;206:256–263.
Li Y, Shi J, Duan X, et al. Transpalpebral measurement of intraocular pressure using the Diaton tonometer versus standard Goldmann applanation tonometry. Graefes Arch Clin Exp Ophthalmol. 2010;248:1765–1770.